Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.320 |
None |
1.000 |
3 |
|
2016 |
2019 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.310 |
None |
1.000 |
2 |
|
2016 |
2019 |
Microcalcification
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Calcinosis
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
52
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumoral calcinosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
45
|
3
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Heart valve disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
79
|
5
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
15 |
|
2006 |
2019 |
Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.080 |
None |
1.000 |
8 |
|
2016 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.060 |
None |
1.000 |
6 |
|
2015 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.060 |
None |
1.000 |
6 |
|
2015 |
2019 |
Septicemia
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1285
|
141
|
0.050 |
None |
1.000 |
5 |
|
2016 |
2019 |
Subarachnoid Hemorrhage
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
501
|
26
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.050 |
None |
1.000 |
5 |
|
2016 |
2019 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.050 |
None |
1.000 |
5 |
|
2009 |
2019 |
Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1135
|
15
|
0.040 |
None |
0.750 |
4 |
|
2016 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Middle Cerebral Artery Occlusion
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Acquired Abnormality
|
626
|
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2020 |